Evidence on the treatment of PSR is scarce, whether it is observation, self-regression, laserpexy to decrease retinal oxygen demand and prevent further ischemia or intravitreal anti-VEGF to temporarily block VEGF [6]. The gene discussed is VEGFA; the disease is ischemia.